300298 Stock Overview
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Sinocare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.89 |
| 52 Week High | CN¥33.28 |
| 52 Week Low | CN¥19.19 |
| Beta | 0.22 |
| 1 Month Change | 14.14% |
| 3 Month Change | 7.32% |
| 1 Year Change | -14.28% |
| 3 Year Change | -31.96% |
| 5 Year Change | 70.64% |
| Change since IPO | 69.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300298 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 3.1% | 3.4% | 1.2% |
| 1Y | -14.3% | -13.1% | -12.6% |
Return vs Industry: 300298 matched the CN Medical Equipment industry which returned -14.1% over the past year.
Return vs Market: 300298 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 300298 volatility | |
|---|---|
| 300298 Average Weekly Movement | 7.1% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 300298 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300298's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 4,531 | Shao Bo Li | www.sinocare.com |
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals.
Sinocare Inc. Fundamentals Summary
| 300298 fundamental statistics | |
|---|---|
| Market cap | CN¥13.23b |
| Earnings (TTM) | CN¥305.61m |
| Revenue (TTM) | CN¥4.19b |
43.3x
P/E Ratio3.2x
P/S RatioIs 300298 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300298 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.19b |
| Cost of Revenue | CN¥1.92b |
| Gross Profit | CN¥2.27b |
| Other Expenses | CN¥1.96b |
| Earnings | CN¥305.61m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.55 |
| Gross Margin | 54.13% |
| Net Profit Margin | 7.29% |
| Debt/Equity Ratio | 25.0% |
How did 300298 perform over the long term?
See historical performance and comparison